Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

NCT03384238 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

PROCEDURE: Fluorescence Imaging
BIOLOGICAL: Panitumumab
DRUG: Panitumumab-IRDye800

Sponsor

George Poultsides

Collaborators

[object Object]